M1 Kliniken AG (XTER:M12) Risk Assessment

View and export this data going back to 2015. Start your Free Trial

What is M1 Kliniken AG Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of M1 Kliniken AG is: Low Risk: Strong fundamentals, worth long-term holding.

Competitive Comparison of M1 Kliniken AG's Risk Assessment

For the Medical Care Facilities subindustry, M1 Kliniken AG's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

M1 Kliniken AG's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, M1 Kliniken AG's Risk Assessment distribution charts can be found below:

* The bar in red indicates where M1 Kliniken AG's Risk Assessment falls into.

M1 Kliniken AG (XTER:M12) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

M1 Kliniken AG Risk Assessment Related Terms

Thank you for viewing the detailed overview of M1 Kliniken AG's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

M1 Kliniken AG (XTER:M12) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » M1 Kliniken AG (XTER:M12) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

M12:Germany M12:Germany M12:Germany

Address

Grunauer strasse 5, Berlin, BB, DEU, 12557

Website

https://www.m1-kliniken.de

M1 Kliniken AG is a healthcare company operating in the market for aesthetic medical treatment and plastic surgery. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. Majority of its revenue derived from Trade segment.

Executives

Kilian Brenske	Board of Directors
Attila Strauss	Board of Directors

M1 Kliniken AG (XTER:M12) Headlines

No Headlines